New CEO and President Takes Up Role at Merck Millipore

Udit Batra, Ph.D, Merck Millipore’s incoming President and CEO has now assumed responsibility for the organisation’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations. Dr. Batra is based at the company’s U.S. headquarters in Massachusetts.

“As a global leader in the Life Sciences industry, I am very humbled and excited to be a part of Merck Millipore team and look forward to serving our customers globally,” Dr. Batra said. “As a former researcher who personally utilised the strong differentiated products that Merck Millipore offers, I have watched this organisation develop over the past several years, and look forward to further building upon that success to bring continued value to our customers and other stakeholders.”

Dr. Batra comes to Merck Millipore from the Consumer Health division of Merck KGaA, where he successfully grew the business in established and emerging markets. He previously worked at Novartis Vaccines & Diagnostics, where he was Head of Global Public Health and Market Access. Prior to that, he served in a range of executive management positions at Novartis, including global Head of Corporate Strategy and Country President for the Pharma Business in Australia.

Dr. Batra is a member of the WSMI (World Self Medication Industry) and the Chair of the Food Supplements Committee of the AESGP (Association of the European Self-Medication Industry).

He holds a Ph.D. in chemical engineering from Princeton University and a bachelor’s degree in chemical engineering from the University of Delaware.